Infectious Disease

Scientists continue to pursue the development of an HIV cure.

A New Zealand woman who was intentionally infected with HIV and was the center of a high profile criminal case faces down numerous challenges related to the virus.

Scientists utilized nanotechnology to improve HIV treatments.

Top news of the day from across the health care landscape.

Fibroblasts in the gastrointestinal tract help HIV infect immune cells.

Gilead’s antiretroviral medication associated with the increased risk of fracture in patients with HIV.

Statins among promising treatment options helping to progress the HIV treatment landscape.

Novel class of inhibitors may be used as a preventive measure for HIV in the future.

Anxiety and depression linked to longer time living with HIV.

New system could improve the implementation of pre-exposure prophylaxis-based care for HIV prevention.

Long-acting antiretroviral maintains significant viral load reduction and increases CD4+ T cells in HIV.

Findings suggest that human genetics trigger mutations in the HIV viral genome.

Have you ever considered pursuing a post-graduate year 2 pharmacy residency in infectious disease?

Mother-to-child transmission rates dropped to 1.9% in 2015.

Antibody that binds to HIV and SIV leads to sustained remission.

Top news of the day from across the health care landscape.

Kaiser report finds the ACA played a significant role in the increase of health insurance for HIV-positive patients.

Structural factors impact access to high-quality HIV prevention and care services.

Top news of the day from across the health care landscape.

Supporters argue current laws are outdated and single out HIV-positive individuals.

Special patient population produces new broadly neutralizing antibodies to defeat HIV.

Conventional HIV drugs could be transformed into once a month dosing.

Treatment with verapamil successfully improved symptoms of chronic rhinosinusitis with nasal polyps.

Manufacturers will present clinical trial results at the upcoming HIV medical meeting.

Gut antibody imbalance may impact immune response to HIV.